Following the Royal College of Psychiatrists’ refusal to retract a public statement minimising the withdrawal effects of antidepressant drugs, and their suppression of research evidence that contradicts their statement, 30 mental health experts have, today, written to the new Secretary of State for Health and Social Care to inform him that “the Royal College of Psychiatrists is currently operating outside the ethical, professional and scientific standards expected of a body representing medical professionals”.
The Rt. Hon. Matt Hancock MP
Secretary of State for Health and Social Care Department of Health
July 17, 2018
Dear Mr Hancock
Ethical, Professional and Scientific Standards of the Royal College of Psychiatrists
We write to you as a group of mental health experts (including eight professors, ten psychiatrists, and ten people who have experienced the withdrawal effects of antidepressants for between 11 months and ten years), because we have become convinced that the Royal College of Psychiatrists (RCPsych) is currently operating outside the ethical, professional and scientific standards expected of a body representing medical professionals.
On April 26, 2018, in the House of Lords, the Earl of Sandwich said:
“On 24 February, the president of the Royal College of Psychiatrists and a colleague wrote in the Times that for “the vast majority of patients, any unpleasant symptoms experienced on discontinuing antidepressants have resolved within two weeks of stopping treatment.
This statement has appalled a large number of psychiatrists and patients who have lodged a complaint with the RCP, including some who have experienced withdrawal effects for between 11 months and 10 years. Even the Royal College’s own survey of 800 users found that withdrawal symptoms generally lasted for up to six weeks, with a quarter reporting that anxiety lasted more than three months. If even one of our leading institutions can mislead Times readers on a matter of public safety, what hope do the Government have of explaining these things to the general public?”
We had originally written to the two senior officials responsible for the misleading statement, but they declined to either retract the statement or provide any compelling research evidence to support it. So we felt it incumbent upon us to register a formal Complaint with the RCPsych about such a misleading and potentially dangerous public statement made by two of its senior leaders, minimizing the seriousness and duration of the withdrawal effects of antidepressants.
The Complaint was dismissed by the Registrar without initiating a full investigation, and without a right of appeal. As is clear from the accompanying documentation, the four stated reasons for the peremptory dismissal were all either irrelevant or untrue.
We have waited four weeks for a response to our last letter to the RCPsych (19.6.2018). It seems we must accept that our endeavours to have the RCPsych respond in a responsible, professional manner to our concerns have come to nought and that we have therefore reached the end of our options for engaging with the RCPsych via its own processes.
Before deciding whether to take our original Complaint about the two senior officials of the RCPsych to the General Medical Council and/or to lodge a Complaint about the RCPsych as an organisation with the Charity Commission because of their subsequent conduct, we ask that you review our requests of the RCPsych (below) and consider intervening, if only to encourage the RCPsych to reconsider those requests (including the simple request to meet with them – #7).
We understand the RCPsych is not directly accountable to yourself or Parliament. We would, nevertheless, ask you to consider suggesting to the RCPsych that it would be in the public interest for them to respond meaningfully to try to resolve the serious issue we have raised.
This is a matter of grave concern since it involves information about prescription medications taken by millions of people across the UK. We feel that this matter requires urgent attention and should not await the results of the Public Health England review into Prescribed Drug Dependence.
Our requests to the RCPsych, which we do feel are in the public interest, follow. They have been given to RCPsych on several occasions and have been consistently either ignored or, dismissed.
We hope you may be in a position to ask RCPsych to respond in a more professional manner, which places the public interest on at least an equal footing as its guild interests.
- Publicly retract, explain and apologise for the misleading statement, in The Times and on the RCPsych website.
- Provide guidance or training for all RCPsych spokespersons, including the current President, on (i) the importance of ensuring that public statements are evidence- based, and (ii) the limitations of relying on colleagues who are in receipt of payments from the pharmaceutical industry (e.g. Professor Baldwin)
- Review policies and procedures relating to the holding of positions of responsibility within the RCPsych by members who are in receipt of drug company payments, including Professor Baldwin.
- Provide new evidence-based information about antidepressants and adverse effects, including withdrawal effects, and guidance about how best to withdraw, to be issued by the RCPsych and generated and agreed on the basis of a joint working group including some of ourselves and withdrawal sufferers.
- Reinstate, on the RCPsych website, the document ‘Coming Off Antidepressants’, including the results of the survey that contradicts the false statement and accurately reflects the experiences of over 800 antidepressant recipients.
- Make a commitment to advocate for more research, using a range of methodologies, into the duration and nature of symptoms following withdrawal from antidepressants, and into tapering protocols and treatments to assist people to withdraw safely.
- Arrange an informal roundtable meeting with Professors Burn and Baldwin and one or two other RCPsych representatives (perhaps chosen jointly by the Disciplinary and Complaints Committee and the President) with an equal number of ourselves, with the goal of moving on from a complaints procedure, and the difficult feelings involved therein, in such a way that we are all genuinely working together, in our inevitably different ways, to, in the words of Professors Burn and Baldwin in their responses above ‘help our patients recover’ and to not only ‘make sure depressed and anxious patients receive the best possible care’ but also those withdrawing from antidepressants.
We have appended the original Complaint, with all the relevant research evidence and correspondence. We believe the RCPsych responses show a trail of obfuscation, dishonesty and inability or unwillingness to engage with a concerned group of professionals, scientists and patients.
If a group of scientists and psychiatrists together cannot challenge the RCPsych in a way that leads to an appropriate, considered response and to productive engagement with the complainants, what hope is there for individual patients to have a complaint taken seriously?
In the interests of public interest and safety, we are making this letter, and any response thereto, public, and copying it to other MPs and members of the House of Lords and the Scottish and Welsh Assemblies with a special interest in mental or public health.
Professor John Read (Clinical Psychology, University of East London)
on behalf of:
Claire Ashby-James (withdrawal effects from Escitalopram – 1 year, 9 months) Berkshire
Emeritus Professor Mary Boyle (Clinical Psychology) University of East London
Dr Pat Bracken (Psychiatry) County Cork
Dr Steven Coles (Clinical Psychology) Nottinghamshire Healthcare NHS Foundation Trust
Dr Duncan Double (Psychiatry) Norfolk and Suffolk NHS Foundation Trust
Tabitha Dow (withdrawal effects from Venlafaxine – 2 years, 4 months) Berkshire
Alyne Duthie (withdrawal effects from Venlafaxine – 4 years) Aberdeenshire
Dr Peter Gordon (withdrawal effects from Paroxetine – 4 years) Stirlingshire
Professor Peter Gøtzsche (Medical Research) University of Copenhagen
Dr Peter Groot (Psychiatry) University of Maastricht
Dr Christopher Harrop (Clinical Psychology) University College London
Carina Håkansson (Psychotherapy) International Institute for Psychiatric Drug Withdrawal Dr Oliver James (Clinical Psychology, Author)
Ann Kelly (withdrawal effects from Fluoxetine & Venlafaxine – 10 years) West Dunbartonshire
Stevie Lewis (withdrawal effects from Paroxetine – 4 years) Monmouthshire
Nora Lindt (withdrawal effects from Venlafaxine – 3 years) Dublin
Dr Hugh Middleton (Psychiatry) University of Nottingham
James Moore (withdrawal effects from Mirtazapine – 11 months) Monmouthshire
Sinead Morris (withdrawal effects from Paroxetine – 3 years) County Antrim
Professor Jim van Os (Psychiatry) University of Maastricht; Institute of Psychiatry, London
Danielle Park (withdrawal effects from Mirtazapine/Depakote – 4 years, 4 months) Kent
Dr Margreet Peutz (Psychiatry) CGG Brussels, Belgium
Professor Nimisha Patel (Clinical Psychology) University of East London
Professor David Pilgrim (Clinical Psychology) University of Southampton
Professor Paula Reavey (Psychology) London South Bank University
Dr Clive Sherlock (Psychiatry) Oxford
Dr Derek Summerfield (Psychiatry) King’s College London
Dr Philip Thomas (Psychiatry) (retired, ex University of Central Lancashire)
Professor Sami Timimi (Psychiatry) Lincolnshire Partnership NHS Foundation Trust
Jo Watson (Psychotherapy) Birmingham
Jackie Doyle-Price MP – Under Secretary of State – Mental Health & Inequalities
Nicola Blackwood MP – Under Secretary of State – Public Health & Innovation
John Ashworth MP – Shadow Secretary of State – Health & Social Care
Paula Sherriff MP – Shadow Minister – Mental Health
Baroness Judith Jolly – Health Spokesperson, Liberal Democrats
Caroline Lucas MP – Co-leader, Green Party
Jeane Freeman MSP (Scottish Assembly) Cabinet Secretary – Health and Sport
Dr Lisa Cameron MP – Mental Health Spokesperson, SNP
Vaughan Gething AM (National Assembly for Wales) – Cabinet Secretary – Health & Social Services
Rhun ap Iorwerth AM (National Assembly for Wales) – Shadow Cabinet Secretary – Health, Well-being & Sport; Plaid Cymru
David Rowlands AM (National Assembly for Wales) Petitions Committee Chair
Sir Oliver Letwin MP – Chair, All Party Parliamentary Group for Prescribed Drug Dependence
Luciana Berger MP – All Party Parliamentary Group for Prescribed Drug Dependence
Paul Flynn MP – All Party Parliamentary Group for Prescribed Drug Dependence
Norman Lamb MP – All Party Parliamentary Group for Prescribed Drug Dependence
The Earl of Sandwich – All Party Parliamentary Group for Prescribed Drug Dependence
Baroness Masham of Ilton -All Party Parliamentary Group for Prescribed Drug Dependence
John McDonnell MP
Jess Phillips MP Eleanor Smith MP
Formal Complaint to the UK Royal College of Psychiatrists
Royal College Of Psychiatrists Challenged Over Potentially Burying Inconvenient Antidepressant Data
Professor John Read: The Royal College of Psychiatrists and Antidepressant Withdrawal
UK Royal College Dismisses Complaint
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Thank you X 1,000,000 for speaking up for us. Bless all of you that are in a position to take a stand and are doing so. We need your help. (9 years off and still hurting but have certainly come a very long ways.)
MY OWN EXPERIENCE OF MH OFFICIALDOM
My GP at London W2 5LT removes “Schizophrenia” in writing with explanation, 3 times :
A month later I see “Schizophrenia” still on the system. So I complain to my GP and he Responds with this Rationale:-
I complain to the General Medical Council; and in May of 2013 I am politely fobbed off:-
MY ORIGINAL MH EXPERIENCE
Thank you so much.
It’s time psychiatry starting telling the truth and stopped being drug pushers. Not change someones diagnoses to borderline personality disorder when they are suffering from heinous symptoms from being made to go cold turkey but never cold turkeying them in the first place and caring for them through withdrawl
Three cheers! Keep it up.
Where is their “Duty of Candour”?
Courageous demand for the basic tenets of ethical medical practice.
Why not distribute to all final year medical students who have just qualified, or who are about to qualify?
Influencing those about to commit their future to specialist medical training might just provoke an attempt to address this eloquent, sincere, valid and evidence based complaint in a manner befitting a Medical Royal College.
TRM 123. Retired Consultant Physician.
Anyone seen the headlines today?
(it is actually a Times story but The Times has a paywall)
Andrea Cipriani quoted as saying “‘People are prescribing antidepressants to people who don’t really need them, who have low mood. ‘It’s important people are aware that antidepressants aren’t a quick fix.’”
Wasn’t Cipriani the same one who said that we need to give out MORE antidepressants?
Yes, in February he was quoted:
‘Andrea Cipriani, from the university’s Department of Psychiatry, said: “Under-treated depression is a huge problem and we need to be aware of that. We tend to focus on over-treatment but we need to focus on this.” ‘
The million more came from John Geddes.
The potential effects of psychiatric drugs in the womb:-
“…Approximately 3 per cent of British women suffer from prenatal depression and take antidepressant pills while pregnant.
Now a study has found babies born to these women have brains different from those of other children – which may make them more susceptible to anxiety disorders in later life…”
From the Daily Mail Article.
Who could POSSIBLY have guessed?
It’s the move towards admission that antidepressants could be damaging childrens brains in the womb and causing problems later on.
“Everyone” was in denial abut this before and women were encouraged to take these drugs while pregnant.
(The RTE Website says “unexpected error” when I try to open this “debate” , and I can’t find the “debate” on YouTube).
Good luck with all of that.
It is very easy to get akathisia on an SSRI especially if you have anxiety/insomnia, because many will look for an alternative to sleeping tablets. The alternatives such as Nytol and many other sleep aids contain valerian which blocks the cytochrome P450 metabolising enzymes triggering akathisia.
For those who do not know about Akathisia – it is an horrific condition and the real cause of a lot of suicide and suicide ideation.
The only real way to prove between any ‘real’ MH cause of suicide and akathisia induced, is for the patient to have a cytochrome P450 gene test and be able to show they consumed things like valerian and other herbs spices and food stuffs that inhibt the metabolising enzymes. They are as common as black tea, black pepper, curcumin in turmeric, garlic, cinnamon, ginger and many others.
The gene test has been known about for a long time. Here from the BBC 18 years ago :
Ofcourse the state and the regulatory bodies know about all this, but the patient is just fodder, a no nowt that is just ignored.
Talking therapies should be the first port of call when any patient suffering from what is considered a mental health issue turns up in a doctors surgery. Doctors have 5 minutes to spend with each patient. Assessing what is wrong is not possible for most people. So there should be alternatives available at doctors surgeries.
Talking therapies should be available. I don’t really no why this has never been approached?
Pharma is a is a drug business not a talk business. Going to a GP with a ‘MH’condition is like getting out of the boat….
More BBC coverage on this today… “Antidepressant prescriptions for children on the rise”
The steepest increase was seen in the youngest patients, those aged 12 and under, where the number of prescriptions rose on average by 24%, from 14,500 to almost 18,000.
Dr Bernadka Dubicka, who chairs the child and adolescent faculty at the Royal College of Psychiatrists, said: “Currently only one in four children and young people are treated for their mental health problems. The fact that prescriptions for antidepressants are rising could reflect a slow but steady move towards treating everyone who is unwell.”
Same old same old from the Royal College of Psychiatrists.
This might be interesting, but will they mention akathisia?
File on 4: Counting the Cost: Anti-depressant Use in Children is on BBC Radio 4 at 20:00 BST on 24 July.
Yes and children are more likely to get akathisia because their metabolising systems are not fully develeoped. Ofcourse when the childs behavious gets worse (akathisia) it is seen as a deepening of the illness not a reaction to the drugging and therefore a rout to more toxic drugging.
Ofcourse later in life children become teenagers, if still on these drugs when they start to drink alcohol….
Then ofcourse the ever possibility of falling down dead:
If you make it past that lot, dementia awaits. For those who wish to read about it – Drug induced Dementia by Grace E Jackson – a master class in research.
I’ve no doubt they are blaming all this on social media.